Register information Patent

DE file number : 60 2016 041 819.3 (Status: pending/in force, Query started: April 24, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2016 041 819.3
96EP file numberEAKZ16 72 2548.1
86WO file numberWAKZPCT/EP2016/059196
97EP publication numberEPN3286562
87WO publication numberWPN2016170187
54Designation/titleTIBIOMARKER ZUR BESTIMMUNG DER KLINISCHEN REAKTION AUF ZELLTHERAPIE
51IPC main classICM
(ICMV)		 G01N 33/50 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 35/28 (2015.01)
22DE application dateDATApr 25, 2016
96EP application dateEATApr 25, 2016
86WO application dateWATApr 25, 2016
43Date of first publicationOTOct 27, 2016
Date of publication of grantPETAug 12, 2020
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
72InventorINDE LA ROSA, Olga, 28760 Tres Cantos, ES; DALEMANS, Wilfried, 28760 Tres Cantos, ES
74RepresentativeVTRMaiwald GmbH, 80335 München, DE
Address for service Maiwald GmbH, 80065 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
EP
15382206
Apr 24, 2015
Due dateFT
FG		Apr 30, 2026
Annual fee for the 11th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003286562A2
Searchable text: EP000003286562A2
Original document: EP000003286562B1
Searchable text: EP000003286562B1
Original document: WO002016170187
Searchable text: WO002016170187
43Date of first publicationEVTOct 27, 2016
Date of the first transfer into DPMAregisterEREGTFeb 28, 2018
Date of the (most recent) update in DPMAregisterREGTMar 28, 2025
(Show all update days)(Hide all update days)
  • Mar 28, 2025
    • Due date: changed
  • Sep 19, 2024
    • St.36: changed (technical change)
  • May 29, 2024; May 8, 2024; Mar 27, 2024; Mar 28, 2023; Oct 24, 2022; Jun 30, 2022; May 25, 2022; Mar 30, 2022; Jul 29, 2021; Jun 24, 2021; Apr 8, 2021; Oct 12, 2020; Sep 10, 2020; Jul 30, 2020; Jul 23, 2020; Aug 22, 2019; May 16, 2019
    • Historical data not available for this/these date(s)
  • Feb 28, 2018
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Oct 27, 2016  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Feb 28, 2018  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Apr 12, 2018 Apr 12, 2018 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Aug 12, 2020  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Sep 10, 2020 Sep 10, 2020 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision May 14, 2021 Jul 29, 2021 Details anzeigen
7 New applicant/owner details New applicant/owner details May 24, 2022 Jun 30, 2022 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTOct 27, 2016
Date of update of the procedureREGTJul 23, 2020
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTFeb 28, 2018
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTApr 12, 2018
Issue numberHN15
YearPJ2018
Publication dateVTApr 12, 2018
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTAug 12, 2020
Date of update of the procedureREGTJul 23, 2020
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTSep 10, 2020
Issue numberHN37
YearPJ2020
Publication dateVTSep 10, 2020
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTSep 10, 2020
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTMay 14, 2021
Issue numberHN30
YearPJ2021
Publication dateVTJul 29, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTJul 29, 2021
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTMay 24, 2022
Issue numberHN26
YearPJ2022
Publication dateVTJun 30, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
71/73Previous applicant/ownerINHFTiGenix, S.A.U., Tres Cantos, Madrid, ES
Date of update of the procedureREGTJun 30, 2022